CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survival-Reference-Cited by-同舟云学术

CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survival

Published:2024-05-24 Issue:1 Volume:13 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Nie Siyue¹²³,Song Yujie²,Hu Kun²,Zu Wei⁴⁵,Zhang Fengjiao²,Chen Lixia²,Ma Qiang²,Zhou Zishan²,Jiao Shunchang³

Affiliation:

1. PLA Medical School, Beijing, China

2. Research and Development Department, Beijing DCTY Biotech Co. LTD, Beijing, China

3. Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China

4. Department of Functional Neurosurgery, Capital Medical University, Beijing, China

5. Department of Functional Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2024.2358590

Reference44 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Signaling pathways and therapeutic interventions in gastric cancer

3. Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells

4. Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo

5. Bifunctional αHER2/CD3 RNA-engineered CART-like human T cells specifically eliminate HER2+ gastric cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Cancer Treatments through Stem Cell-Derived CAR T Cells for Immunotherapy: Opening New Horizons for the Future of Oncology;Cells;2024-09-10

2. Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies;Biomedicine & Pharmacotherapy;2024-09